Ganga Pharmaceuticals MD, chairman, board of directors and AGM
BSE: 539680Pharmaceuticals & Biotechnology
Last traded ₹12.50 on 8 Sep 2026
Ganga Pharmaceuticals board of directors
At the end of the quarter to Mar 2019, as the company filed it; changes since are in its announcements.
- ChairpersonBharat Brijmohan Sharma
- Company Secretary and Compliance OfficerPriti Bhaiya
6 directors3 independent3 executive
- Bharat Brijmohan Sharma · ChairpersonExecutive · joined Apr 2015 · 1 listed board · 1 committee seat
- Sanjay Vyanktesh KulkarniExecutive · joined Apr 2012 · 1 listed board
- Srijna Bharat SharmaExecutive · joined Apr 2012 · 1 listed board · 1 committee seat
- Sachin Chandrakant ChavanIndependent · joined Sep 2014 · 60 months as independent · 1 listed board · 1 committee seat
- Chetan Bhikubhai PatelIndependent · joined Sep 2014 · 60 months as independent · 1 listed board · 2 committee seats, 1 as chair
- Harish Bhagwandas TalrejaIndependent · joined Sep 2015 · 60 months as independent · 1 listed board · 1 committee seat, 1 as chair
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 30 Mar 201960 days in between
- 28 Jan 201983 days in between
- 5 Nov 2018
Audit Committee
Chair Chetan Bhikubhai Patel
Sachin Chandrakant Chavan, Bharat Brijmohan Sharma
- 28 Jan 201983 days in between
Nomination and remuneration committee
Chair Chetan Bhikubhai Patel
Sachin Chandrakant Chavan, Harish Bhagwandas Talreja
No meeting listed in the filing.
Stakeholders Relationship Committee
Chair Harish Bhagwandas Talreja
Srijna Bharat Sharma, Chetan Bhikubhai Patel
- 28 Jan 201983 days in between
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Ganga Pharmaceuticals AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Ganga Pharmaceuticals share news and announcements
Annual general meeting, 26 Sep 2026
364 shareholders on the register on 18 Sep 2026; present: 8 promoters and 2 others; votes counted by Gaurav Thakur / Gaurav Thakur & Co.The company's voting result (opens in a new tab)
1 To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2026 including the Audited Balance Sheet as at March 31, 2026 and the Statement of Profit and Loss for the year ended on that date together with the Reports of the Board of Directors and Auditors thereonMoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · other public 0.00%
Turnout: all 54.16% · promoters 100.00% · other public 6.62%
- 2. To re-appoint Mr. Sanjay Kulkarni (DIN: 00065190) as a Director, who retires by rotation and being eligible, offers himself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 54.16% · promoters 100.00% · other public 6.62%
- 3. Re-appointment of Mr. Bharat Brijmohan Sharma as Managing Director & Chief Executive Officer (CEO) of the CompanyOrdinary100.00% for0.00% against
Against: promoters 0.00% · other public 0.00%
Turnout: all 54.16% · promoters 100.00% · other public 6.62%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Compliance
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- No
- The company has a risk management committee
- No
The company's own answers in its filing.